These findings suggest that periodically depleting activated microglia via short‐term CSF1R inhibition following the onset of AD could be a promising approach to maintain a less proinflammatory environment, reduce mTOR activation, and enhance autophagy for extended periods in the AD brain. Here, CSF1R is linked to Alzheimer disease.